A

vanir Pharmaceuticals is cutting 73 employees in “sales-related positions,” or roughly 11 percent of its workforce, according to a recent filing with California state officials. A spokesman confirmed the move and described it as an effort to “streamline our current approach to sales and better position Avanir to pursue its long-term mission.”

The layoffs occur as that mission is coming under scrutiny.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.